Da An Gene's subsidiary approved for delisting from NEEQ
Da An Gene Of Sun Yat-Sen University (SZSE:002030) announced that its subsidiary, Zhuhai Yasha Biotechnology, has received approval from the NEEQ to terminate its listing. The decision was formalized under document reference [2025]807. As of the announcement, Da An Gene's wholly-owned subsidiary, Guangzhou Da An Gene Technology, holds a 9.2095% stake in Zhuhai Yasha Biotechnology. The delisting is scheduled for June 10, 2025, and Zhuhai Yasha Biotechnology is currently completing the necessary procedures with the China Securities Depository and Clearing Corporation Limited Beijing Branch. Da An Gene clarifies that the delisting of Zhuhai Yasha Biotechnology from the NEEQ will not impact its ordinary business operations and will not have a material impact on the company's production and operations.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Da An Gene Of Sun Yat-Sen University publishes news
Free account required • Unsubscribe anytime